In addition, as an off-the-shelf ACT, adoptive DN T cell therapy has emerged as an ideal therapeutic option for tumors, and DN T cells exhibit cytotoxicity in various hematological malignancies and solid tumors in an Ag-independent manner (Figure 5). The gene discussed is RENBP; the disease is hematologic disorder.